MIRM News and Press, Mirum Pharmaceuticals Inc. From 09/24/25

2025-09-24 14:03:51 ET More on Mirum Pharmaceuticals Mirum Pharmaceuticals, Inc. (MIRM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Mirum Pharmaceuticals: Q2 Results Continue To Show Positive Momentum Mirum Pharmaceuticals, Inc. (MI...

2025-09-08 11:13:49 ET Mirum Pharmaceuticals, Inc. (MIRM) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 8:30 AM EDT... Read the full article on Seeking Alpha For further details see: Mirum Pharmaceuticals, Inc. (MIRM) Presents At Morgan Stanley 23...

- Topline data announcement expected second quarter of 2026 Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced the completion of enrollment in the Phase 2b VISTAS study of volixibat, an investigational oral IBAT inhibitor, for the treatment of cholestatic pruritus in patients wi...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferenc...

2025-08-12 09:37:48 ET Shares of Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) traded at a new 52-week high today and are currently trading at $66.46. So far today, approximately 49,826 shares have been exchanged, as compared to an average 30-day volume of 503k shares. Mirum Pharmaceut...

A look at the top 10 most actives in the United States Wang & Lee Group Inc. (WLGS) rose 41.5% to $0.0648 on volume of 725,817,293 shares Entero Therapeutics Inc. (ENTO) rose 66.5% to $0.6074 on volume of 300,549,439 shares Tilray Brands Inc. (TLRY) rose 41.8% to $0.92 on volume of 242,...

2025-08-11 09:48:37 ET I last took a look at Mirum Pharmaceuticals, Inc. ( MIRM ) in March of this year. I concluded that article stating this biopharma was a solid name to continue to accumulate. Since then, the company has posted two quarters of results. Both of which ...

2025-08-07 12:15:15 ET Raymond James analyst issues STRONG BUY recommendation for MIRM on August 7, 2025 01:34PM ET. The previous analyst recommendation was Strong Buy. MIRM was trading at $59.6501 at issue of the analyst recommendation. The overall analyst consensus : B...

2025-08-06 21:09:53 ET Mirum Pharmaceuticals, Inc. (MIRM) Q2 2025 Earnings Conference Call August 06 2025, 04:30 PM ET Company Participants Andrew McKibben - Senior Vice President, Strategic Finance & Investor Relations Christopher Peetz - CEO & Director ...

2025-08-06 17:06:32 ET More on Mirum Pharmaceuticals Mirum Pharmaceuticals Q2 2025 Earnings Preview Seeking Alpha’s Quant Rating on Mirum Pharmaceuticals Historical earnings data for Mirum Pharmaceuticals Financial information for Mirum Pharmaceuticals...